The current status and optimization strategies of CAR-T cell therapy in hematological malignancies.

Author: Fang Ce WANG ¹ ; Ping LI ¹ ; Ai Bin LIANG ¹
Author Information

1. Department of Hematology, Tongji Hospital of Tongji University, Shanghai 200333, China.
Publication Type:Journal Article
MeSH: Humans; Receptors, Chimeric Antigen; Immunotherapy, Adoptive; Hematologic Neoplasms/therapy*; Cell- and Tissue-Based Therapy
From: Chinese Journal of Internal Medicine 2023;62(6):581-586
CountryChina
Language:Chinese